Each year the firm’s offices in China represent Israeli and international clients engaged in investment activity and M&A transactions in China.
We represent public and private companies, venture capital funds, local, Israeli and international hi-tech companies expanding in China and the US.
In addition to advising on investment and cross border M&A transactions, our attorneys in China advise clients on relevant issues, including transaction structure, third party or regulatory clearance, tax planning, labor law, intellectual property, real estate and much more.
.jpg "The firm represented Mazor Robotics Ltd., in a strategic and complex equity investment by Medtronic")
.jpg "IATI’s forum of public biomed companies")
.jpg "Our firm represented EasyPark, a Swedish company, in it's acquisition of the Israeli company, Parko")
.jpg "Attorneys Mor Limanovich and Marie Orlovsky represented Zeekit Ltd. in a finanacing round of $9 million")
.jpg "Open-Source (?) How not to ruin your venture")
.jpg "Insuline Medical Ltd. raised additional NIS2.2 million")
.jpg "China’s secret: opportunity for Israeli companies to raise financing in China")
.jpg "Another successful financing round of $25 million for SimilarWeb")
.jpg "China (Beijing) International Technology Transfer Convention 2016")
.jpg "Adv. Mor Limanovich represented NSLComm in a financing round of $2.5 million from JVP and additional investors")
